• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

左炔诺孕酮宫内节育系统单独作为年轻早期子宫内膜癌女性的主要治疗方法:病例报告

Levonorgestrel-releasing intrauterine system alone as primary treatment in young women with early endometrial cancer: case report.

作者信息

Fambrini Massimiliano, Bargelli Gianni, Peruzzi Elena, Buccoliero Anna Maria, Pieralli Annalisa, Andersson Karin L, Scarselli Gianfranco, Gallorini Marcella, Zolfanelli Federica, Marchionni Mauro

机构信息

Department of Gynecology, Perinatology, and Human Reproduction, University of Florence, Florence, Italy.

出版信息

J Minim Invasive Gynecol. 2009 Sep-Oct;16(5):630-3. doi: 10.1016/j.jmig.2009.05.007.

DOI:10.1016/j.jmig.2009.05.007
PMID:19835809
Abstract

Young women with polycystic ovary syndrome (PCOS) are at increased risk of endometrial adenocarcinoma (EAC) through chronic unopposed estrogen production. We describe the first case, to our knowledge, of grade 1 endometrioid EAC arising in the context of complex atypical endometrial hyperplasia in a 26-year-old woman with thrombophilia and PCOS who wished to retain fertility potential and was treated using a levonorgestrel-releasing intrauterine system alone. At first follow-up biopsy, a single focus of complex hyperplasia without atypia was documented. All specimens sampled during subsequent follow-up demonstrated inactive endometrium with pseudodecidual changes, and no ultrasonographic or magnetic resonance (MR) images exhibiting myometrial invasion or endoabdominal spread were observed. This successful outcome suggests that insertion of a levonorgestrel-releasing intrauterine system is a treatment option in selected young women with early-stage EAC who are not candidates for systemic therapy and who wish to maintain fertility potential. Close histologic follow-up is required, and immediate surgery is mandatory if endometrial cancer persists.

摘要

患有多囊卵巢综合征(PCOS)的年轻女性由于长期无对抗的雌激素分泌,患子宫内膜腺癌(EAC)的风险增加。据我们所知,我们描述了首例1级子宫内膜样EAC,该病例发生在一名患有血栓形成倾向和PCOS的26岁女性的复杂性非典型子宫内膜增生背景下,该女性希望保留生育潜力,仅使用左炔诺孕酮宫内节育系统进行治疗。在首次随访活检时,记录到一个单一的无非典型性的复杂性增生灶。后续随访期间采集的所有标本均显示为具有假蜕膜样改变的静止子宫内膜,未观察到超声或磁共振(MR)图像显示有肌层浸润或腹腔内播散。这一成功结果表明,对于不适合进行全身治疗且希望维持生育潜力的早期EAC的特定年轻女性,插入左炔诺孕酮宫内节育系统是一种治疗选择。需要密切的组织学随访,如果子宫内膜癌持续存在,则必须立即进行手术。

相似文献

1
Levonorgestrel-releasing intrauterine system alone as primary treatment in young women with early endometrial cancer: case report.左炔诺孕酮宫内节育系统单独作为年轻早期子宫内膜癌女性的主要治疗方法:病例报告
J Minim Invasive Gynecol. 2009 Sep-Oct;16(5):630-3. doi: 10.1016/j.jmig.2009.05.007.
2
Progression of atypical endometrial hyperplasia to adenocarcinoma despite intrauterine progesterone treatment with the levonorgestrel-releasing intrauterine system.尽管使用左炔诺孕酮宫内节育系统进行宫内孕激素治疗,非典型子宫内膜增生仍进展为腺癌。
Obstet Gynecol. 2008 Feb;111(2 Pt 2):547-9. doi: 10.1097/01.AOG.0000300716.84819.c6.
3
Endometrioid adenocarcinoma after insertion of a levonorgestrel-releasing intrauterine system.左炔诺孕酮宫内节育系统置入后发生的子宫内膜样腺癌
J Minim Invasive Gynecol. 2008 Nov-Dec;15(6):771-3. doi: 10.1016/j.jmig.2008.08.016.
4
Treatment with medroxyprogesterone acetate plus levonorgestrel-releasing intrauterine system for early-stage endometrial cancer in young women: single-arm, prospective multicenter study: Korean gynecologic oncology group study (KGOG2009).醋酸甲羟孕酮联合左炔诺孕酮宫内缓释系统治疗年轻早期子宫内膜癌的单臂前瞻性多中心研究:韩国妇科肿瘤学组研究(KGOG2009)。
Jpn J Clin Oncol. 2012 Dec;42(12):1215-8. doi: 10.1093/jjco/hys171. Epub 2012 Oct 15.
5
Is levonorgestrel intrauterine system effective for treatment of early endometrial cancer? Report of four cases and review of the literature.
Gynecol Oncol. 2005 Jun;97(3):924-7. doi: 10.1016/j.ygyno.2004.10.031.
6
Successful twin pregnancy achieved by assisted reproductive technology in a patient with polycystic ovary syndrome with complex atypical endometrial hyperplasia treated with levonorgestrel-releasing intrauterine system.经左炔诺孕酮宫内缓释系统治疗后,多囊卵巢综合征伴复杂非典型子宫内膜增生患者采用辅助生殖技术成功妊娠双胞胎。
Gynecol Endocrinol. 2010 Feb;26(2):125-8. doi: 10.3109/09513590903015569.
7
Levonorgestrel-releasing intrauterine system (LNG-IUS) as an effective treatment option for endometrial hyperplasia: a 15-year follow-up study.左炔诺孕酮宫内缓释系统(LNG-IUS)作为子宫内膜增生的有效治疗选择:一项 15 年随访研究。
Fertil Steril. 2011 Jan;95(1):420-2. doi: 10.1016/j.fertnstert.2010.07.1044. Epub 2010 Aug 19.
8
The effectiveness of a levonorgestrel-releasing intrauterine system (LNG-IUS) in the treatment of endometrial hyperplasia--a long-term follow-up study.左炔诺孕酮宫内节育系统(LNG-IUS)治疗子宫内膜增生的有效性——一项长期随访研究。
Eur J Obstet Gynecol Reprod Biol. 2008 Aug;139(2):169-75. doi: 10.1016/j.ejogrb.2008.02.022. Epub 2008 Apr 28.
9
Stage IV endometrial cancer after failed conservative management: a case report.保守治疗失败后的IV期子宫内膜癌:一例报告
Gynecol Oncol. 2008 Dec;111(3):579-82. doi: 10.1016/j.ygyno.2008.02.027. Epub 2008 Apr 18.
10
Successful pregnancy following insertion of a levonorgestrel-releasing intrauterine system in two infertile patients with complex atypical endometrial hyperplasia.两名患有复杂性非典型子宫内膜增生的不孕患者在植入左炔诺孕酮宫内节育系统后成功受孕。
Gynecol Obstet Invest. 2008;65(4):266-8. doi: 10.1159/000113308. Epub 2008 Jan 15.

引用本文的文献

1
An Update on Contraception in Polycystic Ovary Syndrome.多囊卵巢综合征避孕方法的最新进展。
Endocrinol Metab (Seoul). 2021 Apr;36(2):296-311. doi: 10.3803/EnM.2021.958. Epub 2021 Apr 15.
2
Dilatation and curettage is more accurate than endometrial aspiration biopsy in early-stage endometrial cancer patients treated with high dose oral progestin and levonorgestrel intrauterine system.在接受高剂量口服孕激素和左炔诺孕酮宫内节育系统治疗的早期子宫内膜癌患者中,刮宫术比子宫内膜抽吸活检更准确。
J Gynecol Oncol. 2017 Jan;28(1):e1. doi: 10.3802/jgo.2017.28.e1. Epub 2016 Aug 2.
3
Endometrial adenocarcinoma in a 27-year-old woman.
一名27岁女性的子宫内膜腺癌。
Clin Med Insights Case Rep. 2010;3:31-9. doi: 10.4137/ccrep.s5346. Epub 2010 Aug 12.